10 Things That Make a Commercial Narrative Fall Apart in Diligence

Your science gets you the meeting. Your commercial story determines the terms. Where the pitch is about what investors want to see, diligence is about what survives a hard look once you’re close to a deal. These are the specific ways a commercial narrative comes apart when an investor across the table starts pulling on the details. The fear underneath most raises is the same: that they find the crack you couldn’t see, and the round comes in on worse terms, or doesn’t come in at all.

1. The deck and the data room disagree.

The pitch says one thing; the model, the protocol, and the market work say another. Diligence is built to find that gap, and it usually does.

2. The forecast doesn’t reconcile with the trial.

When the revenue model assumes claims the endpoints won’t support, the whole number stops being credible. The commercial story has to match the study you’re actually running.

3. The market size can’t be rebuilt from the bottom up.

A big market-size number with no funnel under it, from diagnosis to treated patient, is the first thing a good analyst takes apart.

4. The story changes from one meeting to the next.

If the commercial case shifts each time it’s told, it reads as improvised. Diligence rewards a narrative that stays the same under pressure.

5. The analogs don’t hold up when examined.

Flimsy comparisons that fall apart on a second look do more damage than admitting you don’t have a clean precedent.

6. Key assumptions have no owner and no evidence.

If no one can say which assumptions the case rests on, or point to what supports them, the case loses credibility.

7. Access and pricing were never pressure-tested.

A plan that assumes coverage and a price no payer has weighed in on has a hole exactly where the revenue is.

8. The competition is missing or downplayed.

A landscape with no real rivals, or only weak ones, often tells a diligence team you haven’t looked hard enough, or you’re hoping they won’t.

9. There’s no answer for what would break the case.

A narrative with no acknowledged failure points looks rehearsed. The CEO who can say where the case would break earns more trust, not less.

10. The story was clearly built the week before the raise.

Investors will easily clock a commercial case you put together at the last minute. The version that will hold up is the one you’ve been building and testing for years.

Investors can forgive uncertainty. They struggle to forgive the sense that no one has really vetted the commercial side. Diligence isn’t looking for certainty. It’s looking for a clear-eyed case that has been thoroughly considered.